Kerry McEnaney
Overview
Explore the profile of Kerry McEnaney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Angelidou A, Koster J, Sherman A, McLoughlin C, Lalwani P, Kelly A, et al.
NPJ Vaccines
. 2025 Feb;
10(1):35.
PMID: 39971929
Opioid overdose deaths are an evolving public health emergency in the United States. Recent advancements in drug conjugate vaccine design and adjuvantation technologies have re-ignited interest in the potential clinical...
2.
Kouyate T, Nguyen A, Plotkin A, Ford R, Idoko O, Odumade O, et al.
Front Immunol
. 2024 Oct;
15:1425349.
PMID: 39386208
Introduction: Dynamic cellular and molecular adaptations in early life significantly impact health and disease. Upon birth, newborns are immediately challenged by their environment, placing urgent demands on the infant immune...
3.
Martino D, Kresoje N, Amenyogbe N, Ben-Othman R, Cai B, Lo M, et al.
Nat Commun
. 2024 Sep;
15(1):8167.
PMID: 39289350
Understanding of newborn immune ontogeny in the first week of life will enable age-appropriate strategies for safeguarding vulnerable newborns against infectious diseases. Here we conducted an observational study exploring the...
4.
Montante S, Ben-Othman R, Amenyogbe N, Angelidou A, Van den Biggelaar A, Cai B, et al.
J Immunol Res
. 2024 Jul;
2024:1117796.
PMID: 39081632
The first few days of life are characterized by rapid external and internal changes that require substantial immune system adaptations. Despite growing evidence of the impact of this period on...
5.
Hammer P, McEnaney K, Callahan R, Baird C, Hoganson D, Jenkins K
Children (Basel)
. 2021 Sep;
8(9).
PMID: 34572161
Pulmonary vein stenosis is a serious condition characterized by restriction or blockage due to fibrotic tissue ingrowth that develops in the pulmonary veins of infants or children. It is often...
6.
Holzer R, Gauvreau K, McEnaney K, Watanabe H, Ringel R
Circ Cardiovasc Interv
. 2021 May;
14(6):e010308.
PMID: 34039015
Background: Long-term outcome data of stent-implantation for coarctation of the aorta are limited. We report up to 5 years of postimplant follow-up in patients enrolled into the COAST (Coarctation of...
7.
Vignolo S, Diray-Arce J, McEnaney K, Rao S, Shannon C, Idoko O, et al.
J Clin Transl Sci
. 2021 May;
5(1):e52.
PMID: 33948273
The Expanded Program for Immunization Consortium - Human Immunology Project Consortium study aims to employ systems biology to identify and characterize vaccine-induced biomarkers that predict immunogenicity in newborns. Key to...
8.
Callahan R, Gauvreau K, Marshall A, Sena L, Baird C, Ireland C, et al.
Children (Basel)
. 2021 Apr;
8(3).
PMID: 33802089
The purpose of this study was to determine what patient and pulmonary vein characteristics at the diagnosis of intraluminal pulmonary vein stenosis (PVS) are predictive of individual vein outcomes. A...
9.
Zaidi A, Yamada J, Miller D, McEnaney K, Ireland C, Roberts A, et al.
Children (Basel)
. 2021 Feb;
8(2).
PMID: 33578785
Pulmonary vein stenosis (PVS) is a rare, frequently lethal disease with heterogeneous phenotypes and an unclear etiology. Limited studies have reported associations between PVS and congenital heart disease (CHD), chronic...
10.
Idoko O, Smolen K, Wariri O, Imam A, Shannon C, Dibassey T, et al.
Front Pediatr
. 2020 Dec;
8:610461.
PMID: 33313031
[This corrects the article DOI: 10.3389/fped.2020.00197.].